Last reviewed · How we verify
NCT02785601
PK Study of Diet Effect of Trazodone Hydrochloride Prolonged-Released Tablets in Healthy Chinese
Phase 1 trial testing Trazodone Hydrochloride prolonged-release tablets in Depression in 15 participants. Completed in 4 January 2018.
30 November 2017
Quick facts
| Lead sponsor | Lee's Pharmaceutical Limited |
|---|---|
| Phase | Phase 1 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 15 |
| Start date | 1 May 2017 |
| Primary completion | 30 November 2017 |
| Estimated completion | 4 January 2018 |
| Sites | 1 location across Hong Kong |
Drugs / interventions tested
- Trazodone Hydrochloride prolonged-release tablets — full drug profile →
Conditions studied
- Depression — all drugs for Depression →
Sponsor
Lee's Pharmaceutical Limited — full company profile →
Who can join
Adults 19 to 45, any sex, with Depression. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The main objective is to compare the pharmacokinetics in single dose, and effect of food on the trazodone hydrochloride pharmacokinetics prolonged-release tablets.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT02785601
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Depression
Currently open trials in the same condition.
- NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
- NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
- NCT07517549 — Sexual Health Education During Pregnancy · NA · recruiting
- NCT06408246 — ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression · Phase 2 · recruiting
- NCT07449676 — Effects of an Innovative TCM-based Tui Jing Therapy on Psychological and Neurophysiological Functions in Depression · NA · recruiting
Other Lee's Pharmaceutical Limited trials
Trials by the same sponsor.
- NCT06953453 — A Study of Inhaled Fentanyl Aerosol in Chinese Patients With Malignant Tumors · Phase 1 · recruiting
- NCT07099144 — Inhaled Nitric Oxide for the Treatment of Neonatal Hypoxic Respiratory Failure With Pulmonary Hypertension · recruiting
- NCT06459687 — Phase III Study of Socazolimab as First-Line Treatment in Persistent, Recurrent, or Metastatic Cervical Cancer · Phase 3 · recruiting
- NCT06374485 — Study of AU409 Capsule in Advanced Hepatocellular Carcinoma Patients Who Failed Standard Treatment · Phase 1 · recruiting
- NCT05806918 — Non-inferiority Study of ZK-A03 in Treatment of Herpes Zoster Before and After the Alteration of the Active Ingredient M · Phase 3 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02785601 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Lee's Pharmaceutical Limited
- Last refreshed: 5 September 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02785601.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing